US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ArriVent BioPharma

23.43

-1.8200-7.21%

Post-market: 23.430.00000.00%18:21 EST

Volume:1.79M

Turnover:43.07M

Market Cap:1.04B

PE:-5.61

High:26.08

Open:25.41

Low:22.87

Close:25.25

52wk High:27.22

52wk Low:15.47

Shares:44.20M

Float Shares:25.53M

Volume Ratio:3.22

T/O Rate:7.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.1758

EPS(LYR):-2.5577

ROE:-51.84%

ROA:-32.78%

PB:3.40

PE(LYR):-9.16

Loading ...

Overview Company News Filings

U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer

ArriVent BioPharma Initiated at Buy by Truist Securities

Arrivent Biopharma Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $43

THOMSON REUTERS

Truist Initiates ArriVent BioPharma at Buy With $43 Price Target

MT Newswires Live

Stock Track | ArriVent BioPharma Soars 5.21% Ahead of Anticipated Q4 Earnings Report

Stock Track | ArriVent BioPharma Soars 5.21% Ahead of Q4 Earnings Report

Calendar of U.S. Earnings Expected in the Week Ahead

ArriVent BioPharma, Inc.: Strategic Advancements and Promising Developments Drive Buy Rating with $45 Price Target

ArriVent BioPharma Is Maintained at Buy by Citigroup

Stock Track | ArriVent BioPharma Soars 5.05% on Pipeline Updates and Bullish Analyst Rating

Stock Track | ArriVent BioPharma Soars 5.05% on Strong Pipeline Update and Analyst Buy Rating

ArriVent Biopharma Showcases Global Oncology Pipeline and Late-Stage Firmonertinib Program in New Presentation

H.C. Wainwright Keeps Their Buy Rating on ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma Reports Q3 2025 Financial Results

ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating

ArriVent BioPharma Q3 EPS $(0.83) Misses $(0.81) Estimate

ArriVent Biopharma Appoints Brent S. Rice as Chief Commercial Officer

ArriVent Biopharma reports $305.4 million in cash and investments for Q3 2025

Arrivent Biopharma Inc: Q3 EPS $-0.83

THOMSON REUTERS

Arrivent Biopharma Inc: Projects Topline Pivotal Data From Global Phase 3 Trial in Exon 20 Insertion Mutant Nsclc in Early 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/AVBP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AVBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVBP\",,,,,undefined,":{"symbol":"AVBP","market":"US","secType":"STK","nameCN":"ArriVent BioPharma","latestPrice":23.43,"timestamp":1772830800000,"preClose":25.25,"halted":0,"volume":1790364,"hourTrading":{"tag":"盘后","latestPrice":23.43,"preClose":23.43,"latestTime":"18:21 EST","volume":8977,"amount":210222.29,"timestamp":1772839269812,"change":0,"changeRate":0,"amplitude":0.012804},"delay":0,"changeRate":-0.07207920792079209,"floatShares":25528400,"shares":44201622,"eps":-4.175792,"marketStatus":"Not Yet Opened","change":-1.82,"latestTime":"03-06 16:00:00 EST","open":25.41,"high":26.08,"low":22.87,"amount":43072568.16018,"amplitude":0.127129,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.175792,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1773043200000},"marketStatusCode":0,"adr":0,"listingDate":1706245200000,"exchange":"NASDAQ","adjPreClose":25.25,"preHourTrading":{"tag":"盘前","latestPrice":25.2,"preClose":25.25,"latestTime":"09:28 EST","volume":3340,"amount":83394.12868,"timestamp":1772807280013,"change":-0.05,"changeRate":-0.00198,"amplitude":0.02099},"postHourTrading":{"tag":"盘后","latestPrice":23.43,"preClose":23.43,"latestTime":"18:21 EST","volume":8977,"amount":210222.29,"timestamp":1772839269812,"change":0,"changeRate":0,"amplitude":0.012804},"volumeRatio":3.221746160090339,"impliedVol":0.7265,"impliedVolPercentile":0.5833},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AVBP\",,,,,undefined,":{"symbol":"AVBP","floatShares":25528400,"roa":"-32.78%","roe":"-51.84%","lyrEps":-2.557665,"volumeRatio":3.221746160090339,"shares":44201622,"dividePrice":0,"high":26.08,"amplitude":0.127129,"preClose":25.25,"low":22.87,"week52Low":15.47,"pbRate":"3.40","week52High":27.22,"institutionHeld":0,"latestPrice":23.43,"eps":-4.175792,"divideRate":0,"volume":1790364,"delay":0,"ttmEps":-4.175792,"open":25.41,"prevYearClose":20.12,"prevWeekClose":22.97,"prevMonthClose":22.97,"prevQuarterClose":20.12,"fiveDayClose":22.97,"twentyDayClose":21.35,"sixtyDayClose":24.98},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-05","symbol":"AVBP","fiscalQuarterEnding":"2025/12","expectedEps":-0.87,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.78},{"market":"US","date":"2025-11-10","symbol":"AVBP","fiscalQuarterEnding":"2025/09","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-0.83},{"market":"US","date":"2025-08-11","symbol":"AVBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.7,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-0.9},{"market":"US","date":"2025-05-12","symbol":"AVBP","fiscalQuarterEnding":"2025/03","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.9},{"market":"US","date":"2025-03-03","symbol":"AVBP","fiscalQuarterEnding":"2024/12","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AVBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1766466000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AVBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AVBP","date":"2026-03-06","current":-5.610912,"percent":0.613725,"low":-15.980041,"twenty":-11.219707,"median":-8.258082,"eighty":-5.878182,"high":-4.80343,"avg":-8.545164,"sd":2.642972,"marketCap":1116090955},"quantilePoints":[{"date":"2024-01-26","current":-15.452095,"twenty":-15.452095,"median":-15.452095,"eighty":-15.452095,"marketCap":905214654},{"date":"2024-02-02","current":-11.990156,"twenty":-12.001066,"median":-11.872873,"eighty":-10.91006,"marketCap":702407320},{"date":"2024-02-09","current":-12.548731,"twenty":-12.548731,"median":-12.001066,"eighty":-11.75559,"marketCap":735129780},{"date":"2024-02-16","current":-12.588659,"twenty":-12.548731,"median":-12.126596,"eighty":-11.919241,"marketCap":737468829},{"date":"2024-02-23","current":-11.219707,"twenty":-12.556717,"median":-11.998256,"eighty":-11.67237,"marketCap":657272853},{"date":"2024-03-01","current":-12.286349,"twenty":-12.548731,"median":-11.990156,"eighty":-11.204877,"marketCap":719758884},{"date":"2024-03-08","current":-11.464977,"twenty":-12.548731,"median":-11.964074,"eighty":-11.315533,"marketCap":671641299},{"date":"2024-03-15","current":-10.59227,"twenty":-12.5031,"median":-11.767288,"eighty":-11.121598,"marketCap":620516364},{"date":"2024-03-22","current":-10.386927,"twenty":-12.327418,"median":-11.658912,"eighty":-10.920492,"marketCap":608486967},{"date":"2024-03-28","current":-10.267144,"twenty":-12.279504,"median":-11.507757,"eighty":-10.718898,"marketCap":601469820},{"date":"2024-04-05","current":-8.84046,"twenty":-12.261251,"median":-11.265338,"eighty":-10.410884,"marketCap":612935625},{"date":"2024-04-12","current":-8.536116,"twenty":-12.10149,"median":-11.165519,"eighty":-9.961411,"marketCap":591834562},{"date":"2024-04-19","current":-7.487821,"twenty":-11.997694,"median":-11.025772,"eighty":-8.805678,"marketCap":519153125},{"date":"2024-04-26","current":-7.507145,"twenty":-11.992272,"median":-10.91658,"eighty":-8.501334,"marketCap":520492875},{"date":"2024-05-03","current":-8.115832,"twenty":-11.986485,"median":-10.803317,"eighty":-8.191193,"marketCap":562695000},{"date":"2024-05-10","current":-8.079495,"twenty":-11.960082,"median":-10.543786,"eighty":-8.115832,"marketCap":602552562},{"date":"2024-05-17","current":-9.049573,"twenty":-11.929189,"median":-10.386927,"eighty":-8.101297,"marketCap":674899062},{"date":"2024-05-24","current":-8.479203,"twenty":-11.828069,"median":-10.210104,"eighty":-8.115832,"marketCap":632362000},{"date":"2024-05-31","current":-8.739687,"twenty":-11.762609,"median":-9.361752,"eighty":-8.133223,"marketCap":651788375},{"date":"2024-06-07","current":-8.241175,"twenty":-11.7192,"median":-8.959751,"eighty":-8.180566,"marketCap":614610312},{"date":"2024-06-14","current":-8.456747,"twenty":-11.662334,"median":-8.912923,"eighty":-8.216398,"marketCap":630687312},{"date":"2024-06-21","current":-7.455231,"twenty":-11.653208,"median":-8.84046,"eighty":-8.15931,"marketCap":555996250},{"date":"2024-06-28","current":-7.81452,"twenty":-11.61214,"median":-8.79358,"eighty":-8.133223,"marketCap":582791250},{"date":"2024-07-05","current":-8.205246,"twenty":-11.533425,"median":-8.753505,"eighty":-8.152944,"marketCap":611930812},{"date":"2024-07-12","current":-8.268121,"twenty":-11.43988,"median":-8.706383,"eighty":-8.152944,"marketCap":616619937},{"date":"2024-07-15","current":-8.259139,"twenty":-11.414782,"median":-8.695535,"eighty":-8.154535,"marketCap":615950062},{"date":"2024-08-02","current":-9.655872,"twenty":-11.389685,"median":-8.706383,"eighty":-8.156127,"marketCap":720115625},{"date":"2024-08-09","current":-10.262171,"twenty":-11.294999,"median":-8.753505,"eighty":-8.186872,"marketCap":765332187},{"date":"2024-08-16","current":-10.701201,"twenty":-11.237959,"median":-8.81702,"eighty":-8.205246,"marketCap":801359406},{"date":"2024-08-23","current":-10.705686,"twenty":-11.199173,"median":-8.912923,"eighty":-8.209568,"marketCap":801695265},{"date":"2024-08-30","current":-12.010819,"twenty":-11.389685,"median":-8.993434,"eighty":-8.224295,"marketCap":899430214},{"date":"2024-09-06","current":-11.93009,"twenty":-11.657877,"median":-9.253918,"eighty":-8.235785,"marketCap":893384753},{"date":"2024-09-13","current":-10.669806,"twenty":-11.694732,"median":-9.655872,"eighty":-8.248361,"marketCap":799008394},{"date":"2024-09-20","current":-10.85369,"twenty":-11.663166,"median":-9.763659,"eighty":-8.262732,"marketCap":812778610},{"date":"2024-09-27","current":-10.544226,"twenty":-11.657877,"median":-10.060071,"eighty":-8.269917,"marketCap":789604344},{"date":"2024-10-04","current":-11.49056,"twenty":-11.61214,"median":-10.208101,"eighty":-8.279798,"marketCap":860470578},{"date":"2024-10-11","current":-12.463804,"twenty":-11.739278,"median":-10.315491,"eighty":-8.299559,"marketCap":933351966},{"date":"2024-10-18","current":-13.002004,"twenty":-11.938503,"median":-10.371883,"eighty":-8.317243,"marketCap":973655038},{"date":"2024-10-25","current":-13.912458,"twenty":-11.99333,"median":-10.426855,"eighty":-8.325491,"marketCap":1041834400},{"date":"2024-10-31","current":-14.114283,"twenty":-12.114871,"median":-10.539741,"eighty":-8.328911,"marketCap":1056948052},{"date":"2024-11-08","current":-15.980041,"twenty":-12.249611,"median":-10.573379,"eighty":-8.330997,"marketCap":1196665367},{"date":"2024-11-15","current":-11.674764,"twenty":-12.282511,"median":-10.59227,"eighty":-8.332793,"marketCap":946216280},{"date":"2024-11-22","current":-11.05527,"twenty":-12.272349,"median":-10.669806,"eighty":-8.342492,"marketCap":896007510},{"date":"2024-11-29","current":-12.456408,"twenty":-12.274941,"median":-10.685503,"eighty":-8.352544,"marketCap":1009566943},{"date":"2024-12-06","current":-11.870175,"twenty":-12.284404,"median":-10.712096,"eighty":-8.353452,"marketCap":962053946},{"date":"2024-12-13","current":-10.760075,"twenty":-12.274941,"median":-10.748293,"eighty":-8.371867,"marketCap":872082526},{"date":"2024-12-20","current":-10.664448,"twenty":-12.261979,"median":-10.759506,"eighty":-8.380399,"marketCap":864332179},{"date":"2024-12-27","current":-11.46688,"twenty":-12.254096,"median":-10.803317,"eighty":-8.380399,"marketCap":929367700},{"date":"2025-01-03","current":-11.421146,"twenty":-12.244582,"median":-10.85369,"eighty":-8.380399,"marketCap":925661012},{"date":"2025-01-10","current":-11.167527,"twenty":-12.234172,"median":-10.860965,"eighty":-8.382195,"marketCap":905105744},{"date":"2025-01-17","current":-10.177999,"twenty":-12.217129,"median":-10.850538,"eighty":-8.390279,"marketCap":824906501},{"date":"2025-01-24","current":-11.329677,"twenty":-12.196013,"median":-10.850538,"eighty":-8.405549,"marketCap":918247637},{"date":"2025-01-31","current":-12.09469,"twenty":-12.164539,"median":-10.860965,"eighty":-8.437266,"marketCap":980250413},{"date":"2025-02-07","current":-11.383727,"twenty":-12.161213,"median":-10.897572,"eighty":-8.450678,"marketCap":922628268},{"date":"2025-02-14","current":-11.16337,"twenty":-12.157147,"median":-10.9231,"eighty":-8.461238,"marketCap":904768772},{"date":"2025-02-21","current":-11.387884,"twenty":-12.140884,"median":-10.92545,"eighty":-8.479203,"marketCap":922965239},{"date":"2025-02-28","current":-9.8537,"twenty":-12.107163,"median":-10.91658,"eighty":-8.519623,"marketCap":798622715},{"date":"2025-03-07","current":-9.217439,"twenty":-12.09469,"median":-10.885085,"eighty":-8.536116,"marketCap":741893256},{"date":"2025-03-14","current":-9.192082,"twenty":-12.065586,"median":-10.857328,"eighty":-8.618427,"marketCap":739852284},{"date":"2025-03-21","current":-8.258082,"twenty":-12.010819,"median":-10.847386,"eighty":-8.519623,"marketCap":664676489},{"date":"2025-03-28","current":-7.848136,"twenty":-12.001066,"median":-10.781696,"eighty":-8.449161,"marketCap":631680778},{"date":"2025-04-04","current":-7.159258,"twenty":-11.995446,"median":-10.737081,"eighty":-8.380399,"marketCap":576234377},{"date":"2025-04-11","current":-7.125448,"twenty":-11.990156,"median":-10.711139,"eighty":-8.353452,"marketCap":573513081},{"date":"2025-04-17","current":-7.564978,"twenty":-11.988746,"median":-10.703443,"eighty":-8.330997,"marketCap":608889926},{"date":"2025-04-25","current":-8.94696,"twenty":-11.984909,"median":-10.669806,"eighty":-8.330476,"marketCap":720122890},{"date":"2025-05-02","current":-8.908923,"twenty":-11.976101,"median":-10.6604,"eighty":-8.330997,"marketCap":717061432},{"date":"2025-05-09","current":-8.353948,"twenty":-11.95416,"median":-10.580862,"eighty":-8.330997,"marketCap":672392561},{"date":"2025-05-16","current":-5.164444,"twenty":-11.945123,"median":-10.566696,"eighty":-8.323142,"marketCap":658249673},{"date":"2025-05-23","current":-5.537551,"twenty":-11.932894,"median":-10.539741,"eighty":-8.281274,"marketCap":705805133},{"date":"2025-05-30","current":-5.636867,"twenty":-11.923581,"median":-10.506711,"eighty":-8.258716,"marketCap":718463781},{"date":"2025-06-06","current":-6.29987,"twenty":-11.889801,"median":-10.45834,"eighty":-8.241176,"marketCap":802968806},{"date":"2025-06-13","current":-6.342817,"twenty":-11.86768,"median":-10.37894,"eighty":-8.205246,"marketCap":808442816},{"date":"2025-06-20","current":-6.681029,"twenty":-11.831093,"median":-10.360937,"eighty":-8.13004,"marketCap":851550643},{"date":"2025-06-27","current":-6.122711,"twenty":-11.774139,"median":-10.336565,"eighty":-8.056606,"marketCap":780388516},{"date":"2025-07-03","current":-5.951741,"twenty":-11.764948,"median":-10.291317,"eighty":-8.012114,"marketCap":758596999},{"date":"2025-07-11","current":-6.3128,"twenty":-11.752729,"median":-10.177999,"eighty":-7.877518,"marketCap":804616846},{"date":"2025-07-18","current":-6.510523,"twenty":-11.737545,"median":-10.15098,"eighty":-7.814365,"marketCap":829818191},{"date":"2025-07-25","current":-6.146598,"twenty":-11.721024,"median":-10.060071,"eighty":-7.74746,"marketCap":783433107},{"date":"2025-08-01","current":-5.590682,"twenty":-11.706801,"median":-9.819907,"eighty":-7.667253,"marketCap":712577152},{"date":"2025-08-08","current":-5.312724,"twenty":-11.672734,"median":-9.759167,"eighty":-7.57343,"marketCap":677149175},{"date":"2025-08-15","current":-5.522288,"twenty":-11.663891,"median":-9.64689,"eighty":-7.464633,"marketCap":755393737},{"date":"2025-08-22","current":-5.895976,"twenty":-11.659587,"median":-9.496371,"eighty":-7.205647,"marketCap":806510606},{"date":"2025-08-29","current":-5.697269,"twenty":-11.653822,"median":-9.38434,"eighty":-6.898922,"marketCap":779329414},{"date":"2025-09-05","current":-5.789208,"twenty":-11.653208,"median":-9.260758,"eighty":-6.705187,"marketCap":791905786},{"date":"2025-09-12","current":-5.640919,"twenty":-11.550537,"median":-9.192082,"eighty":-6.342817,"marketCap":771621314},{"date":"2025-09-19","current":-5.510425,"twenty":-11.49056,"median":-9.038346,"eighty":-6.3128,"marketCap":753770979},{"date":"2025-09-26","current":-5.092249,"twenty":-11.46688,"median":-8.984996,"eighty":-6.266951,"marketCap":696568768},{"date":"2025-10-03","current":-5.584569,"twenty":-11.464977,"median":-8.939882,"eighty":-6.203238,"marketCap":763913215},{"date":"2025-10-10","current":-6.266699,"twenty":-11.458565,"median":-8.908923,"eighty":-6.178119,"marketCap":857221786},{"date":"2025-10-17","current":-5.820349,"twenty":-11.441934,"median":-8.860202,"eighty":-6.17476,"marketCap":796165526},{"date":"2025-10-24","current":-5.365101,"twenty":-11.433619,"median":-8.84046,"eighty":-6.120027,"marketCap":733892196},{"date":"2025-10-31","current":-5.477801,"twenty":-11.433619,"median":-8.796928,"eighty":-6.098553,"marketCap":749308395},{"date":"2025-11-07","current":-5.454075,"twenty":-11.421146,"median":-8.757651,"eighty":-5.987916,"marketCap":746062880},{"date":"2025-11-14","current":-5.38103,"twenty":-11.41283,"median":-8.728459,"eighty":-5.931566,"marketCap":812417184},{"date":"2025-11-21","current":-5.484932,"twenty":-11.400357,"median":-8.689159,"eighty":-5.895976,"marketCap":828104101},{"date":"2025-11-28","current":-6.2724,"twenty":-11.397031,"median":-8.627903,"eighty":-5.884113,"marketCap":946994421},{"date":"2025-12-05","current":-6.657931,"twenty":-11.389547,"median":-8.556032,"eighty":-5.884113,"marketCap":1005201140},{"date":"2025-12-12","current":-6.649728,"twenty":-11.384558,"median":-8.523142,"eighty":-5.893603,"marketCap":1003962699},{"date":"2025-12-19","current":-5.788435,"twenty":-11.375905,"median":-8.467975,"eighty":-5.893603,"marketCap":873926412},{"date":"2025-12-26","current":-6.094673,"twenty":-11.359859,"median":-8.441726,"eighty":-5.901564,"marketCap":920161536},{"date":"2026-01-02","current":-5.501338,"twenty":-11.346075,"median":-8.391627,"eighty":-5.884113,"marketCap":830580983},{"date":"2026-01-09","current":-5.364625,"twenty":-11.337228,"median":-8.380399,"eighty":-5.844354,"marketCap":809940302},{"date":"2026-01-16","current":-5.988037,"twenty":-11.332171,"median":-8.373482,"eighty":-5.835858,"marketCap":904061805},{"date":"2026-01-23","current":-6.890344,"twenty":-11.326351,"median":-8.3537,"eighty":-5.833294,"marketCap":1040290297},{"date":"2026-01-30","current":-6.152093,"twenty":-11.304731,"median":-8.339979,"eighty":-5.843953,"marketCap":928830622},{"date":"2026-02-06","current":-5.837652,"twenty":-11.270243,"median":-8.329694,"eighty":-5.843953,"marketCap":881357057},{"date":"2026-02-13","current":-6.130218,"twenty":-11.263238,"median":-8.321475,"eighty":-5.843953,"marketCap":925528113},{"date":"2026-02-20","current":-6.313414,"twenty":-11.254838,"median":-8.290577,"eighty":-5.845558,"marketCap":953186625},{"date":"2026-02-27","current":-6.351694,"twenty":-11.246523,"median":-8.270367,"eighty":-5.848589,"marketCap":958966016},{"date":"2026-03-06","current":-6.710988,"twenty":-11.219707,"median":-8.258082,"eighty":-5.878182,"marketCap":1116090955}],"updateTime":1773011869726},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVBP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590054413","title":"U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590054413","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590054413?lang=en_us&edition=fundamental","pubTime":"2025-12-10 14:43","pubTimestamp":1765349009,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-JP Morgan, Pepsico, Pfizer Dec 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including JP Morgan, Pepsi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4N3XG0E5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMC","AVAV","SG9999011175.SGD","APGE","ELAN","APD","ASO","CAT","AMRZ","LU0942090050.USD","CNM","AU","PLAY","LU2133065610.SGD","CPB","CAPR","SATS","CBRL","ASMB","DE","IE00B3PB1722.GBP","BRZE","CMCSA","LU1868836914.USD","AMGN","CF","BIIB","CHD","BLLN","AZO","LU0096364046.USD","BWB","CVS","BMY","LU1868837136.USD","ANF","CARR","COF","AVBP","ABBV","BDX","IE00B894F039.SGD","IE00BDGV0183.EUR","T","DBI","LU2746668974.SGD","ANDE","LU0321505868.SGD","BTI","IE00B19Z9Z06.USD"],"gpt_icon":1},{"id":"2586408769","title":"ArriVent BioPharma Initiated at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2586408769","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586408769?lang=en_us&edition=fundamental","pubTime":"2025-11-26 02:12","pubTimestamp":1764094320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 25, 2025 13:12 ET (18:12 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2586841422","title":"Arrivent Biopharma Inc : Truist Securities Initiates Coverage With Buy Rating; Target Price $43","url":"https://stock-news.laohu8.com/highlight/detail?id=2586841422","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586841422?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:11","pubTimestamp":1764069080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nFWN3X109O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2586422890","title":"Truist Initiates ArriVent BioPharma at Buy With $43 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2586422890","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586422890?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:10","pubTimestamp":1764069017,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) has an average rating of buy and mean price target of $40.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVBP"],"gpt_icon":0},{"id":"1189240324","title":"Stock Track | ArriVent BioPharma Soars 5.21% Ahead of Anticipated Q4 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1189240324","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189240324?lang=en_us&edition=fundamental","pubTime":"2025-11-13 04:38","pubTimestamp":1762979901,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) saw its stock price surge 5.21% during Wednesday's intraday trading session, as investors position themselves ahead of the company's upcoming fourth-quarter earnings report....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVBP"],"gpt_icon":0},{"id":"1154323013","title":"Stock Track | ArriVent BioPharma Soars 5.21% Ahead of Q4 Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1154323013","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154323013?lang=en_us&edition=fundamental","pubTime":"2025-11-13 04:38","pubTimestamp":1762979899,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) saw its stock price surge 5.21% during Wednesday's trading session, as investors show optimism ahead of the company's upcoming fourth-quarter earnings report. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVBP"],"gpt_icon":0},{"id":"2582327400","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2582327400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582327400?lang=en_us&edition=fundamental","pubTime":"2025-11-12 19:00","pubTimestamp":1762945200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·CI&T Inc. Class A                               3Q       .10        AMC. ·Digi Intl Inc.                                  4Q       .51    4:00 PM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATAT","PYPD","ALVO","AUTL","ARDT","AEBI","IBTA","CABA","ARX","ABSI","CSCO","ALMS","CELC","ARCO","BEEM","BABA","ALC","IMRX","AYTU","CINT","TWFG","AFYA","CRMT","GUTS","MGX","ABOS","CLBT","CPRT","ABEO","ACXP","CCAP","ASND","ALUR","AFCG","AKRO","ANNX","ALH","CAAP","CRMD","AEMD","CURI","CREX","AVBP","BLDP","AIRG","AMAT","ATXS","LUNG","RSKD"],"gpt_icon":1},{"id":"2582390854","title":"ArriVent BioPharma, Inc.: Strategic Advancements and Promising Developments Drive Buy Rating with $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2582390854","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582390854?lang=en_us&edition=fundamental","pubTime":"2025-11-12 05:15","pubTimestamp":1762895740,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has maintained their bullish stance on AVBP stock, giving a Buy rating today. Soumit Roy has given his Buy rating d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrivent-biopharma-inc-strategic-advancements-and-promising-developments-drive-buy-rating-with-45-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrivent-biopharma-inc-strategic-advancements-and-promising-developments-drive-buy-rating-with-45-price-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP"],"gpt_icon":0},{"id":"2582392082","title":"ArriVent BioPharma Is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2582392082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582392082?lang=en_us&edition=fundamental","pubTime":"2025-11-12 04:45","pubTimestamp":1762893900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AVBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2025 15:45 ET (20:45 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP"],"gpt_icon":0},{"id":"1146695105","title":"Stock Track | ArriVent BioPharma Soars 5.05% on Pipeline Updates and Bullish Analyst Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1146695105","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146695105?lang=en_us&edition=fundamental","pubTime":"2025-11-12 02:58","pubTimestamp":1762887501,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) saw its stock soar 5.05% in intraday trading on Tuesday, as investors responded positively to the company's latest pipeline updates and a reaffirmed bullish analyst rating....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVBP"],"gpt_icon":0},{"id":"1116309141","title":"Stock Track | ArriVent BioPharma Soars 5.05% on Strong Pipeline Update and Analyst Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1116309141","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116309141?lang=en_us&edition=fundamental","pubTime":"2025-11-12 02:58","pubTimestamp":1762887499,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (AVBP) saw its stock soar 5.05% in intraday trading on Tuesday, following a series of positive developments for the company. The surge comes on the heels of a comprehensive update...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVBP"],"gpt_icon":0},{"id":"2582671793","title":"ArriVent Biopharma Showcases Global Oncology Pipeline and Late-Stage Firmonertinib Program in New Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2582671793","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582671793?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:39","pubTimestamp":1762871941,"startTime":"0","endTime":"0","summary":"ArriVent Biopharma Inc. has outlined updates on its global oncology pipeline, highlighting its lead program, firmonertinib, which has received Breakthrough Therapy Designation for first-line treatment of EGFR Exon 20 insertion mutant non-small cell lung cancer . The company expects topline results from a registrational study in early 2026 and is expanding firmonertinib into a pivotal trial for first-line EGFR PACC mutant NSCLC, supported by positive clinical data. ArriVent is also advancing its next-generation antibody-drug conjugate  portfolio, with ARR-217 currently in Phase 1 trials for gastrointestinal tumors and additional ADC programs expected to enter clinical development in 2026. The pipeline includes multiple programs in various stages targeting solid tumors and NSCLC, with global development efforts outside China. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDLc2DYDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","BK4139"],"gpt_icon":0},{"id":"2582365139","title":"H.C. Wainwright Keeps Their Buy Rating on ArriVent BioPharma, Inc. (AVBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582365139","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582365139?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:56","pubTimestamp":1762862190,"startTime":"0","endTime":"0","summary":"In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on ArriVent BioPharma, Inc., with a price target of $42.00. A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-arrivent-biopharma-inc-avbp-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-arrivent-biopharma-inc-avbp-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP"],"gpt_icon":0},{"id":"2582339086","title":"ArriVent BioPharma Reports Q3 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2582339086","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582339086?lang=en_us&edition=fundamental","pubTime":"2025-11-11 12:27","pubTimestamp":1762835260,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma, Inc. ( ($AVBP) ) has released its Q3 earnings. Here is a breakdown of the information ArriVent BioPharma, Inc. presented to its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-reports-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arrivent-biopharma-reports-q3-2025-financial-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AVBP"],"gpt_icon":0},{"id":"2582938254","title":"ArriVent BioPharma’s Promising Trial Results and Strategic Developments Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2582938254","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582938254?lang=en_us&edition=fundamental","pubTime":"2025-11-11 08:25","pubTimestamp":1762820711,"startTime":"0","endTime":"0","summary":"Sam Slutsky, an analyst from LifeSci Capital, maintained the Buy rating on ArriVent BioPharma, Inc.. The associated price target was lowered to $36...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arrivent-biopharmas-promising-trial-results-and-strategic-developments-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arrivent-biopharmas-promising-trial-results-and-strategic-developments-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVBP"],"gpt_icon":0},{"id":"2582797808","title":"ArriVent BioPharma Q3 EPS $(0.83) Misses $(0.81) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582797808","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582797808?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:05","pubTimestamp":1762779931,"startTime":"0","endTime":"0","summary":"ArriVent BioPharma (NASDAQ:AVBP) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.81) by 2.85 percent. This is a 36.07 percent decrease over losses of $(0.61) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48749577/arrivent-biopharma-q3-eps-0-83-misses-0-81-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP"],"gpt_icon":0},{"id":"2582879755","title":"ArriVent Biopharma Appoints Brent S. Rice as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879755","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879755?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:03","pubTimestamp":1762779809,"startTime":"0","endTime":"0","summary":"ArriVent Biopharma Inc. has appointed Brent S. Rice as Chief Commercial Officer. Rice joins the company with over 25 years of commercial experience in the biotechnology and pharmaceutical industry, most recently serving as Senior Vice President and global Chief Commercial Officer at Autolus Therapeutics Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ArriVent Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL5xDT0P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","BK4139"],"gpt_icon":0},{"id":"2582879440","title":"ArriVent Biopharma reports $305.4 million in cash and investments for Q3 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2582879440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582879440?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:02","pubTimestamp":1762779729,"startTime":"0","endTime":"0","summary":"ArriVent Biopharma Inc. reported a net loss of $130.8 million for the nine months ended September 30, 2025, compared to a net loss of $59.9 million for the same period in 2024. Research and development expenses were $121.2 million, up from $58.8 million in 2024, including a $40 million one-time upfront payment for the in-licensing of ARR-217. General and administrative expenses reached $17.5 million, compared to $11.8 million in 2024. Net cash used in operations was $129.9 million for the period, up from $54.1 million the previous year. As of September 30, 2025, cash and investments totaled $305.4 million, expected to fund operations into mid-2027. Key business developments included FDA IND clearance for ARR-217, ongoing Phase 1 study in China, and the appointment of Brent S. Rice as Chief Commercial Officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-gen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9L9ymq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVBP","IE00B64PRP62.GBP","LU2210149790.SGD","BK4585","LU2095319765.USD","NDAQ","LU2210150020.SGD","BK4139","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4112","BK4588","LU0314104364.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2582871579","title":"Arrivent Biopharma Inc: Q3 EPS $-0.83","url":"https://stock-news.laohu8.com/highlight/detail?id=2582871579","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582871579?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA6CWBHH:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVBP","BK4139"],"gpt_icon":0},{"id":"2582287159","title":"Arrivent Biopharma Inc: Projects Topline Pivotal Data From Global Phase 3 Trial in Exon 20 Insertion Mutant Nsclc in Early 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2582287159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582287159?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:00","pubTimestamp":1762779606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nTUA6CWBHH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AVBP","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}